Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics
RVNC Price/Volume Stats
| Current price | $3.80 | 52-week high | $9.74 |
| Prev. close | $3.76 | 52-week low | $2.30 |
| Day low | $3.68 | Volume | 1,472,000 |
| Day high | $3.92 | Avg. volume | 2,755,682 |
| 50-day MA | $5.24 | Dividend yield | N/A |
| 200-day MA | $4.61 | Market Cap | 398.63M |
RVNC Stock Price Chart Interactive Chart >
Revance Therapeutics, Inc. (RVNC) Company Bio
Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company was founded in 1999 and is based in Newark, California.
RVNC Price Returns
| 1-mo | -28.17% |
| 3-mo | -42.42% |
| 6-mo | 40.22% |
| 1-year | -47.87% |
| 3-year | -72.78% |
| 5-year | -77.07% |
| YTD | -56.77% |
| 2023 | -52.38% |
| 2022 | 13.11% |
| 2021 | -42.41% |
| 2020 | 74.61% |
| 2019 | -19.37% |
Continue Researching RVNC
Here are a few links from around the web to help you further your research on Revance Therapeutics Inc's stock as an investment opportunity:Revance Therapeutics Inc (RVNC) Stock Price | Nasdaq
Revance Therapeutics Inc (RVNC) Stock Quote, History and News - Yahoo Finance
Revance Therapeutics Inc (RVNC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...